Lantheus Holdings Inc (LNTH)

NASDAQ HEALTHCARE
$99.64 -1.35% Daily RSI (14) 42 Neutral As of Jul 31, 2026 Add Alert

Moving Averages

SMA 200
$74.67
Price above

Company Profile

Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment of heart, cancer and other diseases worldwide. The company is headquartered in North Billerica, Massachusetts.

Sector
HEALTHCARE
Industry
DRUG MANUFACTURERS - SPECIALTY & GENERIC
Market Cap
$6.88B
P/E Ratio
25.21
EPS
$4.19
Beta
-0.057
Dividend Yield
0.00%
52-Week High
$111.86
52-Week Low
$47.25

Similar stocks in DRUG MANUFACTURERS - SPECIALTY & GENERIC

HIMS
Hims & Hers Health Inc - Class A
RSI 42.0
CGC
Canopy Growth Corporation
RSI 45.0
BFRI
Biofrontera Inc
RSI 59.0
TLRY
Tilray Brands Inc - Class 2
RSI 56.0
ACB
Aurora Cannabis Inc
RSI 51.0
BCRX
Biocryst Pharmaceuticals Inc
RSI 42.0
INM
InMed Pharmaceuticals Inc
RSI 43.0
ORGO
Organogenesis Holdings Inc - Class A
RSI 44.0
ZTS
Zoetis Inc - Class A
RSI 57.0
AQST
Aquestive Therapeutics Inc
RSI 52.0

Data last updated: July 14, 2026 at 2:42 AM EDT

Track LNTH for free

Get e-mail RSI alerts when Lantheus Holdings Inc enters oversold or overbought territory. Free forever.

Add Alert